Yunqi Capital opposes STAAR Surgical merger with Alcon
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Amazon launches bond sale seeking at least $25 billion
- Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
- Exclusive-China's DeepSeek developing its own AI chip, sources say
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon
October 6, 2025 4:01 PM EDTSTAAR Continues to Significantly Underestimate the Strength of the Business and Future Prospects and Misrepresent Its Performance, Competitive Position, and Market Penetration
Incentives for STAARs CEO Are Not Aligned with Shareholders
Shareholders Should Preserve the Value of Their Investment and Vote Against the Proposed Merger
HONG KONG--(BUSINESS WIRE)-- Yunqi Capital Limited (together with its affiliates and the funds it advises, Yunqi Capital), an investment management firm and 5.1% shareholder of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), today... More
